返回
Sihuan Pharmaceutical Holdings Group Ltd（SHPHY）價格
SHPHY 股價走勢圖
SHPHY 財務
Sihuan Pharmaceutical Holdings Group Ltd
$0
0%
$0
收盤價：Feb 13, 16:00:00 GMT-5
$0
0%
$0
盤後：Feb 13, 20:00:00 GMT-5
收入
資產負債表
現金流量
年度
每季
SHPHY 收入
財務數據以百萬美元計。會計年度為二月至一月。
Follow-Up Questions
Sihuan Pharmaceutical Holdings Group Ltd 的關鍵財務報表是什麼？
SHPHY 的關鍵財務比率是什麼？
Sihuan Pharmaceutical Holdings Group Ltd 的收入按細分市場或地理位置如何劃分？
Sihuan Pharmaceutical Holdings Group Ltd 是否盈利？
Sihuan Pharmaceutical Holdings Group Ltd 有負債嗎？
Sihuan Pharmaceutical Holdings Group Ltd 的流通股有多少？
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
--
每股盈餘 (TTM)
--
股息收益率
--
市值
--
什麼是 SIHUAN PHARMACEUTICAL HOLD GP L？
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 2,767 full-time employees. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.